🔎 Trials Near Me

Home › Parkinson's Disease › NCT06719583

Black and African Americans Connections to Parkinson's Disease (BLAAC PD)

RecruitingObservational studyHealthy volunteers welcome

Black and African Americans Connections to Parkinson's Disease (BLAAC PD) A Project of the Global Parkinson's Genetics Program (GP2)

Who can join

Ages 18 and older · All sexes · Healthy volunteers welcome

Full eligibility criteria
Inclusion Criteria for Control Participants:

* Ability to provide informed consent
* Age 50 years or older
* Self-identify as Black or African American

Exclusion Criteria for Control Participants:

* Diagnosis of Parkinson's Disease and/or neurological condition
* Familial history of PD and/or neurodegenerative or psychiatric conditions
* Unknown family history of PD and/or neurodegenerative or psychiatric conditions
* Any conditions that, in the investigator's opinion, preclude the individual's ability to carry out study activities
* If submitting a saliva sample, nothing by mouth (food, drink, gum, tobacco, or smoking) for 30 minutes prior to sample collection

Inclusion Criteria for Participants with a Diagnosis of PD:

* Ability to provide informed consent
* Age 18 years or older
* Self-identify as Black or African American
* Meet the Movement Disorder Society's clinical diagnostic criteria for Parkinson's disease

Exclusion Criteria for Participants with a Diagnosis of PD:

\- If submitting a saliva sample, nothing by mouth (food, drink, gum, tobacco, or smoking) for 30 minutes prior to sample collection

About the study

BLAAC PD is a research study to understand what Parkinson's disease looks like for Black and African American communities.

BLAAC PD is happening at research centers around the United States. The study is part of the Global Parkinson's Genetics Program (GP2). GP2 is a research project working to transform understanding of the genetics of Parkinson's disease and make that knowledge globally relevant.

Sponsor: Michael J. Fox Foundation for Parkinson's Research · Participants: 2,000 · Started: Nov 16, 2020

Contact the study team

Official record on ClinicalTrials.gov — NCT06719583

Locations in the U.S.

AlabamaUniversity of Alabama at Birmingham, Birmingham
FloridaUniversity of Florida, Gainesville
IllinoisRush University, Chicago
University of Chicago, Chicago
LouisianaOchsner Clinic Foundation, New Orleans
Louisiana State University Health Sciences Center Shreveport, Shreveport
MarylandUniversity of Maryland, Baltimore
MissouriWashington University in St. Louis, St Louis
OhioUniversity Hospitals Cleveland Medical Center, Cleveland
South CarolinaMedical University of South Carolina, Charleston
TexasUniversity of Texas Health Science Center, Houston, Houston

Conditions

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.